Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
5,800.00
+290.00 (5.26%)
Jun 9, 2026, 3:30 PM KST
66.43% (1Y)
| Market Cap | 152.50B +64.5% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 91.32 |
| Forward PE | n/a |
| Dividend | 30.00 (0.51%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 283,349 |
| Open | 5,510.00 |
| Previous Close | 5,510.00 |
| Day's Range | 5,500.00 - 5,970.00 |
| 52-Week Range | 3,380.00 - 15,960.00 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |